MGFA has partnered with Bionews to feature the “Myasthenia Gravis News” feed on our MGFA website. We are excited to offer the MG Community this insightful and informative news feed that covers many aspects of living with myasthenia – from research and study results to managing MG, helpful tips, and important news from across the MG World.
Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, BioNews seeks the opinion of outside experts for interviews and Q&As.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- Soleo Health opens infusion center in Knoxville areaby Andrea Lobo on December 19, 2024 at 3:00 pm
Soleo Health, a pharmacy services company specializing in infusion treatments, has opened a new ambulatory center in the Knoxville, Tennessee, area for people with myasthenia gravis (MG) and other complex The post Soleo Health opens infusion center in Knoxville area appeared first on Myasthenia Gravis News.
- MG has taken so much from me, including my style and fashionby Sarah Bendiff on December 19, 2024 at 3:00 pm
My bitter and best friend myasthenia gravis (MG) takes up a lot of space in my life: in my relationships, my daily routine, and my career choice. I’ve also realized The post MG has taken so much from me, including my style and fashion appeared first on Myasthenia Gravis News.
- IVIG treatment for MG linked with high medical costs in Norway: Studyby Katherine Poinsatte, PhD on December 18, 2024 at 1:00 pm
Myasthenia gravis (MG) patients in Norway who were treated with intravenous immunoglobulin (IVIG) had 2.3 times higher direct medical costs during the first year after a diagnosis than those who The post IVIG treatment for MG linked with high medical costs in Norway: Study appeared first on Myasthenia Gravis News.
- Statin treatment may increase risk of MG onset, worsening: Studyby Katherine Poinsatte, PhD on December 17, 2024 at 4:00 pm
Patients should be monitored for symptoms of myasthenia gravis (MG) for approximately six months after starting treatment with statins, common blood cholesterol-lowering medications, according to a study. Hong Kong-based researchers The post Statin treatment may increase risk of MG onset, worsening: Study appeared first on Myasthenia Gravis News.
- The color teal has meaning in myasthenia gravis — and moreby Shawna Barnes on December 16, 2024 at 3:00 pm
Blue used to be my favorite color. After I was diagnosed with myasthenia gravis (MG), I found myself being drawn more and more to the darker shades of teal. A The post The color teal has meaning in myasthenia gravis — and more appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.